ORF Genetics develops plant-based growth factors, utilizing barley to produce recombinant human and animal proteins for various applications including cell culture and regenerative medicine.

ORF Genetics

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

Corteva, Inc.

IntegriCulture Inc. is a cellular agriculture company that specializes in developing the CulNet system, a general-purpose large-scale cell culture technology applicable to bio-reagents, cosmetics, supplements, and cell-based meat. The company focuses on reducing the cost of cell cultivation by mimicking natural processes found in the body and is committed to developing 3-dimensional tissue engineering methods and high-value byproducts of cell culture for various applications.

Yuki Hanyu

IntegriCulture Inc.

Fraunhofer IWES is involved in research and development related to wind energy systems and hydrogen technology. It focuses on validating technologies necessary for energy transition and planning offshore wind farms. The institute works on various projects that contribute to sustainable energy solutions.

Metric
Company Name	ORF Genetics	Corteva, Inc.	IntegriCulture Inc.	Fraunhofer IWES
Symbol		CTVA
MSH ID	COM:ORFGENETICS	COM:CORTEVA	COM:INTEGRICULTURE	DE:FRAUNHOFER:IWES
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Basic Materials	Consumer Goods	Technology
Industry	Biotechnology	Agricultural Inputs	Cellular Agriculture	Renewable Energy
Country	IS	US	JP	DE
Stage		Post-IPO Debt
Employee Count		22.50K	15
Website	orfgenetics.com	corteva.com	integriculture.com	iwes.fraunhofer.de
LinkedIn			integriculture
Founders

Metric
Market Cap		35.56B
Enterprise Value
Monthly Web Traffic		215.13K
Web Traffic Growth		0.07
Valuation
Raised Capital		1.20B

Metric
Revenue		17.23B
Revenue (LTM)
Revenue (NTM)
Gross Profit		17.23B
EBITDA		941M
Operating Income		941M
Net Income		735M
EPS		1.04
Diluted EPS		1.03
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.42
Operating Profit Margin		0.13
EBITDA Margin		0.05
Net Profit Margin		0.05
Return on Equity		0.04
Return on Assets		0.02
Return on Capital Employed		0.07

ORFG

COM:ORFGENETICS

ORF Genetics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		38.67
P/B Ratio		1.45
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		2.43
EV Multiple		13.87

Metric
Days Sales Outstanding		138.50
Days Payables Outstanding		133.39
Days Inventory Outstanding		253.84
Operating Cycle		401.94
Cash Conversion Cycle		267.85
Asset Turnover		0.41

Metric
Operating Cash Flow		1.77B
Free Cash Flow		1.17B
Cash Flow to Debt		0.71
Operating Cash Flow/Sales		0.15
Free Cash Flow Yield		-0.00

Metric
Cash & Equivalents		2.64B
Accounts Receivable		358M
Inventory		6.90B
Goodwill		10.61B
Debt to Capitalization		0.16
Debt to Assets		0.14
Current Ratio		1.58
Quick Ratio		1.17

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.00
R&D to Revenue		0.08
SG&A to Revenue		0.04